Experimental autoimmune encephalomyelitis

• New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders (07 Aug 2022)
  
• Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination (05 Aug 2022)
  
• Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders (31 Jul 2022)
  
• Medicinal Cannabis and Central Nervous System Disorders (31 Jul 2022)
  
• Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty (31 Jul 2022)